These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11426085)

  • 21. Use of patch testing for the diagnosis of abacavir-related hypersensitivity reaction in HIV patients.
    Giorgini S; Martinelli C; Tognetti L; Carocci A; Giuntini R; Mastronardi V; Torricelli F; Leoncini F; Lotti T
    Dermatol Ther; 2011; 24(6):591-4. PubMed ID: 22515676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abacavir rechallenge has to be avoided in case of hypersensitivity reaction.
    Escaut L; Liotier JY; Albengres E; Cheminot N; Vittecoq D
    AIDS; 1999 Jul; 13(11):1419-20. PubMed ID: 10449301
    [No Abstract]   [Full Text] [Related]  

  • 23. [HLA-B*5701 and abacavir hypersensitivity reaction].
    Servonnet A; Leclercq E; Delacour H; Ceppa F
    Pathol Biol (Paris); 2010 Dec; 58(6):e95-100. PubMed ID: 19243901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abacavir-induced hepatotoxicity: a report of two cases.
    Soni S; Churchill DR; Gilleece Y
    AIDS; 2008 Nov; 22(18):2557-8. PubMed ID: 19005287
    [No Abstract]   [Full Text] [Related]  

  • 25. Abacavir hypersensitivity.
    Vandekerckhove L; Blot S; Vogelaers D
    N Engl J Med; 2008 Jun; 358(23):2514-5; author reply 2515-6. PubMed ID: 18525052
    [No Abstract]   [Full Text] [Related]  

  • 26. Neuropsychiatric reaction induced by abacavir in a pediatric human immunodeficiency virus-infected patient.
    Soler Palacin P; Aramburo A; Moraga FA; Cabañas MJ; Figueras C
    Pediatr Infect Dis J; 2006 Apr; 25(4):382. PubMed ID: 16568000
    [No Abstract]   [Full Text] [Related]  

  • 27. Cytokine profiling in abacavir hypersensitivity patients.
    Almeida CA; Martin AM; Nolan D; Lucas A; Cameron PU; James I; Phillips E; Mallal S
    Antivir Ther; 2008; 13(2):281-8. PubMed ID: 18505179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe abacavir hypersensitivity reaction in a patient tested HLA-B*5701 negative.
    Bonta PI; Vermeulen JN; Speelman P; Prins JM
    AIDS; 2008 Jul; 22(12):1522-3. PubMed ID: 18614879
    [No Abstract]   [Full Text] [Related]  

  • 29. Advances in HIV therapeutics: news from the 4th International AIDS Society Conference.
    Boyle BA; Elion R; Cohen CJ; DeJesus E; Hawkins T; Moyle GJ
    AIDS Read; 2007 Oct; 17(10):484-90. PubMed ID: 17990370
    [No Abstract]   [Full Text] [Related]  

  • 30. Genetic variations in HLA-B region and hypersensitivity reactions to abacavir.
    Hetherington S; Hughes AR; Mosteller M; Shortino D; Baker KL; Spreen W; Lai E; Davies K; Handley A; Dow DJ; Fling ME; Stocum M; Bowman C; Thurmond LM; Roses AD
    Lancet; 2002 Mar; 359(9312):1121-2. PubMed ID: 11943262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic cough induced by abacavir apart from a context of hypersensitivity.
    Peyrière H; Mauboussin JM; Arnaud A; Rouanet I; Vincent D
    Allerg Immunol (Paris); 2002 Dec; 34(10):359-60. PubMed ID: 12575618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Correlation, in previously treated HIV-1 positive patients, between hypersensitivity reaction to abacavir and the presence of the HLA-B*5701 allele].
    Pérez Prior N; Rocher Milla A; Soler Company E; Flores Cid J; Sarria Chust B
    Farm Hosp; 2009; 33(3):155-60. PubMed ID: 19712599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heart attack risk with abacavir and didanosine.
    AIDS Patient Care STDS; 2008 Apr; 22(4):346-7. PubMed ID: 18434947
    [No Abstract]   [Full Text] [Related]  

  • 34. Agranulocytosis induced by abacavir.
    Tikhomirov V; Namek K; Hindes R
    AIDS; 1999 Jul; 13(11):1420-1. PubMed ID: 10449302
    [No Abstract]   [Full Text] [Related]  

  • 35. HLA-B*5701 genetic screening prior to abacavir prescription in Georgia.
    Dvali N; Chkhartishvili N; Sharvadze L; Karchava M; Tsertsvadze T
    Georgian Med News; 2010 Dec; (189):16-20. PubMed ID: 21252404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The abacavir hypersensitivity reaction: a review.
    Clay PG
    Clin Ther; 2002 Oct; 24(10):1502-14. PubMed ID: 12462283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of abacavir and efavirenz: new antiretroviral drugs to treat HIV-1 infection.
    Wolbach J; Capoccia K
    Nurse Pract; 1999 Jun; 24(6):81-2, 87-90, 92. PubMed ID: 10431297
    [No Abstract]   [Full Text] [Related]  

  • 38. A simple screening approach to reduce B*5701-associated abacavir hypersensitivity on the basis of sequence variation in HIV reverse transcriptase.
    Chui CK; Brumme ZL; Brumme CJ; Yip B; Phillips EJ; Montaner JS; Harrigan PR
    Clin Infect Dis; 2007 Jun; 44(11):1503-8. PubMed ID: 17479950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug hypersensitivity in HIV.
    Phillips E; Mallal S
    Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):324-30. PubMed ID: 17620824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropsychiatric reaction induced by abacavir.
    Colebunders R; Hilbrands R; De Roo A; Pelgrom J
    Am J Med; 2002 Nov; 113(7):616. PubMed ID: 12459415
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.